The present invention relates to a pharmaceutical composition for prolonged release of nevirapine, comprising nevirapine or a pharmaceutically acceptable salt thereof as the sole pharmaceutically active ingredient and polyethylene oxide as a matrix-forming component, wherein the amount of the polyethylene oxide with at least 20 wt.-%, based on the total weight of the pharmaceutical composition.
